Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141747 |
| CAS No | NA |
| Mol.F. | C12H16N6O5 |
| Mol.Wt. | 324.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141748 |
| CAS No | NA |
| Mol.F. | C24H39N3O6 |
| Mol.Wt. | 465.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141749 |
| CAS No | NA |
| Mol.F. | C25H41N3O6 |
| Mol.Wt. | 479.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141750 |
| CAS No | NA |
| Mol.F. | C15H23N7O6 |
| Mol.Wt. | 397.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141751 |
| CAS No | NA |
| Mol.F. | C24H39N3O6 |
| Mol.Wt. | 465.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141752 |
| CAS No | NA |
| Mol.F. | C29H43N13O11 |
| Mol.Wt. | 749.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141753 |
| CAS No | 155386-25-7 |
| Mol.F. | C66H74Cl2N10O25 |
| Mol.Wt. | 1478.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141754 |
| CAS No | NA |
| Mol.F. | C21H21BrFN5O3 |
| Mol.Wt. | 490.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141755 |
| CAS No | NA |
| Mol.F. | C17H17FN2O4 |
| Mol.Wt. | 332.3 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141756 |
| CAS No | NA |
| Mol.F. | C24H23F2N3O3 |
| Mol.Wt. | 439.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141757 |
| CAS No | NA |
| Mol.F. | C17H18FN3O3 |
| Mol.Wt. | 331.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141758 |
| CAS No | NA |
| Mol.F. | C23H21F2N3O3 |
| Mol.Wt. | 425.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141759 |
| CAS No | NA |
| Mol.F. | C17H18FN3O3 |
| Mol.Wt. | 331.3 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141760 |
| CAS No | NA |
| Mol.F. | C18H19FN2O4 |
| Mol.Wt. | 346.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141761 |
| CAS No | NA |
| Mol.F. | C17H18FN3O3 |
| Mol.Wt. | 331.3 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141762 |
| CAS No | 24642-83-9 |
| Mol.F. | C9H12N2O |
| Mol.Wt. | 164.2 |
| INV STATUS | CUSTOM SYNTHESIS |